Yossi Maimon

2018 - Protalix BioTherapeutics

In 2018, Yossi Maimon earned a total compensation of $557.6K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 27% decrease compared to previous year.

Compensation breakdown

Bonus$140,000
Option Awards$59,089
Salary$282,649
Other$75,813
Total$557,551

Maimon received $282.6K in salary, accounting for 51% of the total pay in 2018.

Maimon also received $140K in bonus, $59.1K in option awards and $75.8K in other compensation.

Rankings

In 2018, Yossi Maimon's compensation ranked 11,521st out of 14,244 executives tracked by ExecPay. In other words, Maimon earned more than 19.1% of executives.

ClassificationRankingPercentile
All
11,521
out of 14,244
19th
Division
Manufacturing
4,648
out of 5,758
19th
Major group
Chemicals And Allied Products
1,757
out of 2,119
17th
Industry group
Drugs
1,493
out of 1,808
17th
Industry
Biological Products, Except Diagnostic Substances
287
out of 339
15th

Pay ratio

Yossi Maimon's Pay$557,551
Median Employee's Pay$47,782
Pay Ratio

12

to 1

In 2018, the annual total compensation of Yossi Maimon was $557,551.

The annual total compensation of the median employee at Protalix BioTherapeutics was $47,782.

The ratio of Yossi Maimon's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 12, 2019.

Maimon's colleagues

We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2018.

2018

Moshe Manor

Protalix BioTherapeutics

Chief Executive Officer

2018

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2018

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2018

Yaron Naos

Protalix BioTherapeutics

Senior Vice President, Operations

News

You may also like